反应条件
(SPY-5-31)-dichloro-(κ2(C,O)-(2-isopropyloxybenzylidene))(1,3-bis(2,4,6-trimethylphenyl)-4,5-dihydroimidazol-2-ylidene)ruthenium
参考文献
METABOLIX, INC.; van Walsem, Johan; Anderson, Erik; Licata, John; Sparks, Kevin A.; Mirley, Christopher; Sivasubramanian, M.S.
Patent: US2014/24769 A1, 2014 ;
Location in patent: Paragraph 0160; 0162 ;